Benefits and drawbacks of statins and non-statin lipid lowering agents in carotid artery disease.
Paraskevas KI, Gloviczki P, Antignani PL, Comerota AJ, Dardik A, Davies AH, Eckstein HH, Faggioli G, Fernandes E Fernandes J, Fraedrich G, Geroulakos G, Golledge J, Gupta A, Gurevich VS, Jawien A, Jezovnik MK, Kakkos SK, Knoflach M, Lanza G, Liapis CD, Loftus IM, Mansilha A, Nicolaides AN, Pini R, Poredos P, Proczka RM, Ricco JB, Rundek T, Saba L, Schlachetzki F, Silvestrini M, Spinelli F, Stilo F, Suri JS, Svetlikov AV, Zeebregts CJ, Chaturvedi S, Veith FJ, Mikhailidis DP.
Paraskevas KI, et al.
Prog Cardiovasc Dis. 2022 Jul-Aug;73:41-47. doi: 10.1016/j.pcad.2022.05.003. Epub 2022 May 20.
Prog Cardiovasc Dis. 2022.
PMID: 35605696
Review.
International guidelines strongly recommend statins alone or in combination with other lipid-lowering agents to lower low-density lipoprotein cholesterol (LDL-C) levels for patients with asymptomatic/symptomatic carotid stenosis (AsxCS/SCS). Lowering LDL-C levels is associ …
International guidelines strongly recommend statins alone or in combination with other lipid-lowering agents to lower low-density lipoprotei …